Format

Send to

Choose Destination
BMJ. 2002 Oct 19;325(7369):860.

Implementing intensive control of blood glucose concentration and blood pressure in type 2 diabetes in England: cost analysis (UKPDS 63).

Author information

1
Health Economics Research Centre, Department of Public Health, University of Oxford, Institute of Health Sciences, Oxford OX3 7LF. alastair.gray@ihs.ox.ac.uk

Abstract

OBJECTIVE:

To estimate the incremental cost of implementing policies for intensive control of blood glucose concentration and blood pressure for all patients with type 2 diabetes in England.

DESIGN:

Extrapolation of resource use and cost data derived from a randomised controlled trial.

SETTING:

General practice, outpatient care, and inpatient care.

POPULATION:

Trial population with diagnosed type 2 diabetes in England extrapolated to the population of England.

MAIN OUTCOME MEASURES:

Total costs based on use of healthcare resources including costs of management, treatment, and hospitalisation.

RESULTS:

The incremental net annual cost of implementing intensive control of blood glucose and blood pressure to all people with diagnosed type 2 diabetes in England is estimated to be pound 100.5m ($156m; euro;159m), which is equivalent to less than 1% of the proposed additional annual expenditure on the NHS in 2001-5. This estimate varied in sensitivity analyses from pound 67m to pound 121m.

CONCLUSIONS:

Policies to improve control of blood glucose and blood pressure of people with type 2 diabetes are effective in reducing complications associated with the disease and are also cost effective. The total cost represents a small fraction of the NHS's spending plans.

PMID:
12386035
PMCID:
PMC129631
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center